Literature DB >> 18321241

Alitretinoin: a comprehensive review.

Caleb Cheng1, Jason Michaels, Noah Scheinfeld.   

Abstract

BACKGROUND: Alitretinoin (9-cis-retinoic acid) is a unique panagonist retinoid, capable of binding to all six known retinoid receptors (RAR-alpha, -beta, -gamma, and RXR-alpha, -beta, -gamma). Studies are being carried out to determine how best to utilize this characteristic in treatments for conditions such as chronic hand dermatitis.
OBJECTIVE: To review the literature on alitretinoin.
METHODS: The scope of the review encompasses ways that alitretinoin is currently and may potentially be utilized. RESULTS/
CONCLUSIONS: Orally administered alitretinoin is a safe and effective treatment for chronic hand dermatitis. Topical treatment with alitretinoin can be expanded into other areas such as photoaged skin and cutaneous T-cell lymphoma. Despite these benefits, oral alitretinoin will face a difficult path attaining approval for use in the US.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18321241     DOI: 10.1517/13543784.17.3.437

Source DB:  PubMed          Journal:  Expert Opin Investig Drugs        ISSN: 1354-3784            Impact factor:   6.206


  18 in total

1.  The key role of aquaporin 3 and aquaporin 10 in the pathogenesis of pompholyx.

Authors:  D C Soler; X Bai; L Ortega; T Pethukova; S T Nedorost; D L Popkin; K D Cooper; T S McCormick
Journal:  Med Hypotheses       Date:  2015-02-11       Impact factor: 1.538

Review 2.  A review of the molecular design and biological activities of RXR agonists.

Authors:  Nathalia Rodrigues de Almeida; Martin Conda-Sheridan
Journal:  Med Res Rev       Date:  2019-04-03       Impact factor: 12.944

3.  [Successful treatment of Darier disease with oral alitretinoin].

Authors:  S E Barnstedt
Journal:  Hautarzt       Date:  2012-02       Impact factor: 0.751

4.  Identification of 9-cis-retinoic acid as a pancreas-specific autacoid that attenuates glucose-stimulated insulin secretion.

Authors:  Maureen A Kane; Alexandra E Folias; Attilio Pingitore; Mariarita Perri; Kristin M Obrochta; Charles R Krois; Erika Cione; Joo Yeon Ryu; Joseph L Napoli
Journal:  Proc Natl Acad Sci U S A       Date:  2010-11-29       Impact factor: 11.205

5.  Successful treatment of palmoplantar hyperkeratotic psoriasis with a combination of etanercept and alitretinoin.

Authors:  Volker Meyer; Tobias Goerge; Thomas A Luger; Stefan Beissert
Journal:  J Clin Aesthet Dermatol       Date:  2011-04

6.  Evaluation of retinoic acid therapy for OTX2-positive medulloblastomas.

Authors:  Renyuan Bai; I-Mei Siu; Betty M Tyler; Verena Staedtke; Gary L Gallia; Gregory J Riggins
Journal:  Neuro Oncol       Date:  2010-02-05       Impact factor: 12.300

Review 7.  [Alitretinoin: a new treatment option for chronic refractory hand eczema].

Authors:  S Molin; T Ruzicka
Journal:  Hautarzt       Date:  2008-09       Impact factor: 0.751

Review 8.  Hand dermatitis: an allergist's nightmare.

Authors:  Lindsey Wold; Jennifer K Chen; Heather P Lampel
Journal:  Curr Allergy Asthma Rep       Date:  2014-11       Impact factor: 4.806

9.  Update on the use of alitretinoin in treating chronic hand eczema.

Authors:  Pedram Ghasri; Noah Scheinfeld
Journal:  Clin Cosmet Investig Dermatol       Date:  2010-04-19

10.  Alitretinoin--its use in intractable hand eczema and other potential indications.

Authors:  Bibi Petersen; Gregor B E Jemec
Journal:  Drug Des Devel Ther       Date:  2009-09-21       Impact factor: 4.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.